Clinical Trials in Pennsylvania

Showing 8601-8620 of 14,950 trials

Assessing Dietary Requirements in Relation to Resting Metabolic Rate in Spinal Cord Injury

NCT03518892

Assess the relationship between body composition, metabolism, and dietary needs in people with spinal cord injury compared to their healthy controls that are age and sex matched.

Spinal Cord InjuriesDietary Habits

Milton S. Hershey Medical Center16 participantsStarted Mar 2018

Hershey, Pennsylvania, United States

UNKNOWN40 miles

Registry Evaluation of a Double Balloon Accessory Device

NCT03942965

This study is collecting standard of care information pertaining to the use of the accessory device and patient outcomes when this double balloon accessory device is used during endoscopic procedures in the colon.

Adenomatous Polyp of Colon

Lumendi, LLC165 participantsStarted Jan 2019

Gainesville, Florida, United States • Danville, Pennsylvania, United States • Houston, Texas, United States

COMPLETEDPhase 165 miles

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients

NCT02089087

This is a first-in-human study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single intravenous and subcutaneous doses of CFZ533 in healthy subjects and intravenous doses in rheumatoid arthritis patients.

Rheumatoid Arthritis

Novartis Pharmaceuticals75 participantsStarted Jan 2013

Anniston, Alabama, United States • Miami, Florida, United States • South Miami, Florida, United States +3 more locations

Assessing Dietary Requirements in Relation to Resting Metabolic Rate in Spinal Cord Injury

Registry Evaluation of a Double Balloon Accessory Device

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients

Find Trials by Condition in Pennsylvania

Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain

Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol

A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications

Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation

Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

Robotic Bronchoscopy for Peripheral Pulmonary Lesions

An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis

Evaluation of Biomarkers of Traumatic Brain Injury

Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis

The CDR Implementation Trial

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis)

A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma.